We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Refer to the Brain Tumor and Neuro-Oncology Center

University Hospitals Seidman Cancer Center

Please call 216-844-6054, option 3.
For hospital transfers, please call 216-844-1111


Andrew E. Sloan, MD, FACS
Professor & Vice Chairman, Department of Neurosurgery
Peter D. Cristal Chair of Neurosurgical Oncology
Director, Brain Tumor & Neuro-Oncology Center
Director, Center of Excellence, Translational Neuro-Oncology

Brian Bonder, MD
Assistant Professor of Medical Oncology

Serah Choi, MD
Assistant Professor of Radiation Oncology
Director of Brain & Spine Radiosurgery

Alia Hdeib, MD
Assistant Professor of Neurosurgery
Director of Spinal Metastasis Program

Tiffany Hodges, MD
Assistant Professor of Neurosurgery

Conditions Treated

  • Primary brain tumors: Glioblastoma multiforme (GBM) , astrocytoma, oligodendroglioma, ependymoma, hemangioblastoma, meningioma, schwanoma, pituitary adenoma, medulloblastoma, pilocytic astrocytoma, ganglioglioma, pleomorphic xanthrocytoma (PXA)
  • Pineal neoplasms
  • Skull base tumors (chordoma, chondrosarcoma)
  • Metastatic brain tumors
  • Leptomeningeal metastasis
  • Spine tumors (primary and metastatic)
  • Peripheral nerves tumors
  • Neurofibromatosis
  • Radiation necrosis of the brain


  • Image-guided (stereotactic) surgery
  • Skull base surgery
  • Minimally invasive techniques (keyhole surgery)
  • Laser interstitial thermotherapy (LITT) and stereotactic laser ablation (SLA)
  • Stereotactic radiosurgery: Gamma Knife® radiosurgery for brain tumorss
  • Proton therapy
  • Convection enhanced delivery
  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Stem cell therapies
  • Cell-based therapies
  • Gene therapy
  • Antiangiogenic therapy
  • Hyperbaric oxygen for radiation necrosis

Distinguishing Features

  • Part of NCI-designated Case Comprehensive Cancer Center
  • Multidisciplinary consultation with disease-specific tumor boards
  • Personalized therapies incorporating genetic and genomic analysis and genomic tumor board
  • National leadership in clinical trials: Adult Brain Tumor Consortium (ABTC) and NRG
  • 3T intraoperative MRI (iMRI) and Surgical Theater Rehearsal Platform for patient-specific surgical rehearsal
  • Advanced imaging including MRI, MRA, PET-MRI and MR fingerprinting
  • Genetic risk assessment to guide preventive strategies in cancer-prone families
  • Validated nomograms for patient-specific prognosis
  • Supportive and Integrative Oncology and Adolescent and Young Adult (AYA) cancer programs